The Team
.jpg/:/cr=t:12.33%25,l:0%25,w:100%25,h:66.64%25/rs=w:1209,h:1209,cg:true)
Sameer Hassamal, MD. CEO and Founder
Dr. Hassamal is a quadruple board certified, fellowship trained psychiatrist with subspecialty training in addiction psychiatry, addiction medicine, and brain injury medicine. He pursued his residency at Virginia Commonwealth University and subspecialty training at UCLA and Cedars Sinai Medical Center. During his tenure, Dr. Hassamal has pursued several research initiatives both as a Principal Research Investigator and Medical Advisor. In addition to being a prolific author, Dr. Hassamal has held key leadership positions in several healthcare start-ups and has a faculty appointment at the California University of Sciences and Medicine. Dr. Hassamal's vision as the founder and CEO of The California Neuropsychiatric Institute centers on delivering the most advanced and innovative treatments to patients.
Please see a listing of peer reviewed publications: https://scholar.google.com/citations?user=9T0aC_8AAAAJ&hl=en
Please see a listing of editorials to GoodRx: https://www.goodrx.com/about/bio/sameer-hassamal
Areas of Specialty
MENTAL HEALTH CONDITIONS
At the California Neuropsychiatric Institute, we specialize in assessing and treating the whole spectrum of mental health conditions, including treatment resistant cases. Newly approved drugs by the FDA and evidence-based pharmacotherapies are an integral part of the treatment plan.
Neurocognitive disorders
Cognitive enhancing therapies, behavioral interventions, and anti-agitative therapeutics maybe recommended to reduce behavioral disturbances.
Addictive disorders
The institute specializes in treating drug and behavioral addictions. Examples of behavioral addictions are gambling, food, and compulsive sexual behaviors.